1 Market Overview

1.1 Product Overview and Scope of Citalopram

1.2 Classification of Citalopram by Type

1.2.1 Overview: Global Citalopram Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Citalopram Revenue Market Share by Type in 2020

1.2.3 Solution

1.2.4 Tablets

1.2.5 Other

1.3 Global Citalopram Market by Application

1.3.1 Overview: Global Citalopram Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Depression

1.3.3 Generalized Anxiety

1.3.4 Obsessive Compulsive Disorder

1.3.5 Somatoform Disorder

1.3.6 Schizophrenia

1.3.7 Other

1.4 Global Citalopram Market Size & Forecast

1.5 Global Citalopram Market Size and Forecast by Region

1.5.1 Global Citalopram Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Citalopram Market Size by Region, (2016-2021)

1.5.3 North America Citalopram Market Size and Prospect (2016-2026)

1.5.4 Europe Citalopram Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Citalopram Market Size and Prospect (2016-2026)

1.5.6 South America Citalopram Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Citalopram Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Citalopram Market Drivers

1.6.2 Citalopram Market Restraints

1.6.3 Citalopram Trends Analysis

2 Company Profiles

2.1 H.Lundbeck A/S

2.1.1 H.Lundbeck A/S Details

2.1.2 H.Lundbeck A/S Major Business

2.1.3 H.Lundbeck A/S Citalopram Product and Solutions

2.1.4 H.Lundbeck A/S Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 H.Lundbeck A/S Recent Developments and Future Plans

2.2 Amneal Pharmaceuticals

2.2.1 Amneal Pharmaceuticals Details

2.2.2 Amneal Pharmaceuticals Major Business

2.2.3 Amneal Pharmaceuticals Citalopram Product and Solutions

2.2.4 Amneal Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Amneal Pharmaceuticals Recent Developments and Future Plans

2.3 Aurobindo Pharma

2.3.1 Aurobindo Pharma Details

2.3.2 Aurobindo Pharma Major Business

2.3.3 Aurobindo Pharma Citalopram Product and Solutions

2.3.4 Aurobindo Pharma Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Aurobindo Pharma Recent Developments and Future Plans

2.4 Hetero Drugs

2.4.1 Hetero Drugs Details

2.4.2 Hetero Drugs Major Business

2.4.3 Hetero Drugs Citalopram Product and Solutions

2.4.4 Hetero Drugs Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Hetero Drugs Recent Developments and Future Plans

2.5 Macleods Pharmaceuticals

2.5.1 Macleods Pharmaceuticals Details

2.5.2 Macleods Pharmaceuticals Major Business

2.5.3 Macleods Pharmaceuticals Citalopram Product and Solutions

2.5.4 Macleods Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Macleods Pharmaceuticals Recent Developments and Future Plans

2.6 Silarx Pharmacueticals

2.6.1 Silarx Pharmacueticals Details

2.6.2 Silarx Pharmacueticals Major Business

2.6.3 Silarx Pharmacueticals Citalopram Product and Solutions

2.6.4 Silarx Pharmacueticals Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Silarx Pharmacueticals Recent Developments and Future Plans

2.7 Apotex

2.7.1 Apotex Details

2.7.2 Apotex Major Business

2.7.3 Apotex Citalopram Product and Solutions

2.7.4 Apotex Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Apotex Recent Developments and Future Plans

2.8 Hikma Pharmaceuticals

2.8.1 Hikma Pharmaceuticals Details

2.8.2 Hikma Pharmaceuticals Major Business

2.8.3 Hikma Pharmaceuticals Citalopram Product and Solutions

2.8.4 Hikma Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Hikma Pharmaceuticals Recent Developments and Future Plans

2.9 Jubilant Pharma

2.9.1 Jubilant Pharma Details

2.9.2 Jubilant Pharma Major Business

2.9.3 Jubilant Pharma Citalopram Product and Solutions

2.9.4 Jubilant Pharma Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Jubilant Pharma Recent Developments and Future Plans

2.10 Lupin Limited

2.10.1 Lupin Limited Details

2.10.2 Lupin Limited Major Business

2.10.3 Lupin Limited Citalopram Product and Solutions

2.10.4 Lupin Limited Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Lupin Limited Recent Developments and Future Plans

2.11 Prinston Pharmaceutical

2.11.1 Prinston Pharmaceutical Details

2.11.2 Prinston Pharmaceutical Major Business

2.11.3 Prinston Pharmaceutical Citalopram Product and Solutions

2.11.4 Prinston Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Prinston Pharmaceutical Recent Developments and Future Plans

2.12 STI Pharma

2.12.1 STI Pharma Details

2.12.2 STI Pharma Major Business

2.12.3 STI Pharma Citalopram Product and Solutions

2.12.4 STI Pharma Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 STI Pharma Recent Developments and Future Plans

2.13 TEVA Pharmaceutical

2.13.1 TEVA Pharmaceutical Details

2.13.2 TEVA Pharmaceutical Major Business

2.13.3 TEVA Pharmaceutical Citalopram Product and Solutions

2.13.4 TEVA Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 TEVA Pharmaceutical Recent Developments and Future Plans

2.14 Hexal

2.14.1 Hexal Details

2.14.2 Hexal Major Business

2.14.3 Hexal Citalopram Product and Solutions

2.14.4 Hexal Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Hexal Recent Developments and Future Plans

2.15 Shanghai Great Wall Pharmaceutical

2.15.1 Shanghai Great Wall Pharmaceutical Details

2.15.2 Shanghai Great Wall Pharmaceutical Major Business

2.15.3 Shanghai Great Wall Pharmaceutical Citalopram Product and Solutions

2.15.4 Shanghai Great Wall Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Shanghai Great Wall Pharmaceutical Recent Developments and Future Plans

2.16 Wanquan Wante Pharmaceutical

2.16.1 Wanquan Wante Pharmaceutical Details

2.16.2 Wanquan Wante Pharmaceutical Major Business

2.16.3 Wanquan Wante Pharmaceutical Citalopram Product and Solutions

2.16.4 Wanquan Wante Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Wanquan Wante Pharmaceutical Recent Developments and Future Plans

2.17 Northeast Pharmaceutical Group

2.17.1 Northeast Pharmaceutical Group Details

2.17.2 Northeast Pharmaceutical Group Major Business

2.17.3 Northeast Pharmaceutical Group Citalopram Product and Solutions

2.17.4 Northeast Pharmaceutical Group Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Northeast Pharmaceutical Group Recent Developments and Future Plans

2.18 Sichuan Kelun Pharmaceutical

2.18.1 Sichuan Kelun Pharmaceutical Details

2.18.2 Sichuan Kelun Pharmaceutical Major Business

2.18.3 Sichuan Kelun Pharmaceutical Citalopram Product and Solutions

2.18.4 Sichuan Kelun Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Sichuan Kelun Pharmaceutical Recent Developments and Future Plans

2.19 Kunming Jida Pharmaceutical

2.19.1 Kunming Jida Pharmaceutical Details

2.19.2 Kunming Jida Pharmaceutical Major Business

2.19.3 Kunming Jida Pharmaceutical Citalopram Product and Solutions

2.19.4 Kunming Jida Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Kunming Jida Pharmaceutical Recent Developments and Future Plans

2.20 Jiangsu Enhua Pharmaceutical

2.20.1 Jiangsu Enhua Pharmaceutical Details

2.20.2 Jiangsu Enhua Pharmaceutical Major Business

2.20.3 Jiangsu Enhua Pharmaceutical Citalopram Product and Solutions

2.20.4 Jiangsu Enhua Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Jiangsu Enhua Pharmaceutical Recent Developments and Future Plans

2.21 Southwest Pharmaceutical

2.21.1 Southwest Pharmaceutical Details

2.21.2 Southwest Pharmaceutical Major Business

2.21.3 Southwest Pharmaceutical Citalopram Product and Solutions

2.21.4 Southwest Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Southwest Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Citalopram Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Citalopram Players Market Share

3.2.2 Top 10 Citalopram Players Market Share

3.2.3 Market Competition Trend

3.3 Citalopram Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Citalopram Revenue and Market Share by Type (2016-2021)

4.2 Global Citalopram Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Citalopram Revenue Market Share by Application (2016-2021)

5.2 Citalopram Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Citalopram Revenue by Type (2016-2026)

6.2 North America Citalopram Revenue by Application (2016-2026)

6.3 North America Citalopram Market Size by Country

6.3.1 North America Citalopram Revenue by Country (2016-2026)

6.3.2 United States Citalopram Market Size and Forecast (2016-2026)

6.3.3 Canada Citalopram Market Size and Forecast (2016-2026)

6.3.4 Mexico Citalopram Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Citalopram Revenue by Type (2016-2026)

7.2 Europe Citalopram Revenue by Application (2016-2026)

7.3 Europe Citalopram Market Size by Country

7.3.1 Europe Citalopram Revenue by Country (2016-2026)

7.3.2 Germany Citalopram Market Size and Forecast (2016-2026)

7.3.3 France Citalopram Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Citalopram Market Size and Forecast (2016-2026)

7.3.5 Russia Citalopram Market Size and Forecast (2016-2026)

7.3.6 Italy Citalopram Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Citalopram Revenue by Type (2016-2026)

8.2 Asia-Pacific Citalopram Revenue by Application (2016-2026)

8.3 Asia-Pacific Citalopram Market Size by Region

8.3.1 Asia-Pacific Citalopram Revenue by Region (2016-2026)

8.3.2 China Citalopram Market Size and Forecast (2016-2026)

8.3.3 Japan Citalopram Market Size and Forecast (2016-2026)

8.3.4 South Korea Citalopram Market Size and Forecast (2016-2026)

8.3.5 India Citalopram Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Citalopram Market Size and Forecast (2016-2026)

8.3.7 Australia Citalopram Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Citalopram Revenue by Type (2016-2026)

9.2 South America Citalopram Revenue by Application (2016-2026)

9.3 South America Citalopram Market Size by Country

9.3.1 South America Citalopram Revenue by Country (2016-2026)

9.3.2 Brazil Citalopram Market Size and Forecast (2016-2026)

9.3.3 Argentina Citalopram Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Citalopram Revenue by Type (2016-2026)

10.2 Middle East & Africa Citalopram Revenue by Application (2016-2026)

10.3 Middle East & Africa Citalopram Market Size by Country

10.3.1 Middle East & Africa Citalopram Revenue by Country (2016-2026)

10.3.2 Turkey Citalopram Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Citalopram Market Size and Forecast (2016-2026)

10.3.4 UAE Citalopram Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Citalopram Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Citalopram Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Citalopram Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Citalopram Revenue (USD Million) by Region (2016-2021)

Table 5. Global Citalopram Revenue Market Share by Region (2021-2026)

Table 6. H.Lundbeck A/S Corporate Information, Head Office, and Major Competitors

Table 7. H.Lundbeck A/S Major Business

Table 8. H.Lundbeck A/S Citalopram Product and Solutions

Table 9. H.Lundbeck A/S Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Amneal Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 11. Amneal Pharmaceuticals Major Business

Table 12. Amneal Pharmaceuticals Citalopram Product and Solutions

Table 13. Amneal Pharmaceuticals Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Aurobindo Pharma Corporate Information, Head Office, and Major Competitors

Table 15. Aurobindo Pharma Major Business

Table 16. Aurobindo Pharma Citalopram Product and Solutions

Table 17. Aurobindo Pharma Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Hetero Drugs Corporate Information, Head Office, and Major Competitors

Table 19. Hetero Drugs Major Business

Table 20. Hetero Drugs Citalopram Product and Solutions

Table 21. Hetero Drugs Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Macleods Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 23. Macleods Pharmaceuticals Major Business

Table 24. Macleods Pharmaceuticals Citalopram Product and Solutions

Table 25. Macleods Pharmaceuticals Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Silarx Pharmacueticals Corporate Information, Head Office, and Major Competitors

Table 27. Silarx Pharmacueticals Major Business

Table 28. Silarx Pharmacueticals Citalopram Product and Solutions

Table 29. Silarx Pharmacueticals Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Apotex Corporate Information, Head Office, and Major Competitors

Table 31. Apotex Major Business

Table 32. Apotex Citalopram Product and Solutions

Table 33. Apotex Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Hikma Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 35. Hikma Pharmaceuticals Major Business

Table 36. Hikma Pharmaceuticals Citalopram Product and Solutions

Table 37. Hikma Pharmaceuticals Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Jubilant Pharma Corporate Information, Head Office, and Major Competitors

Table 39. Jubilant Pharma Major Business

Table 40. Jubilant Pharma Citalopram Product and Solutions

Table 41. Jubilant Pharma Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Lupin Limited Corporate Information, Head Office, and Major Competitors

Table 43. Lupin Limited Major Business

Table 44. Lupin Limited Citalopram Product and Solutions

Table 45. Lupin Limited Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Prinston Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 47. Prinston Pharmaceutical Major Business

Table 48. Prinston Pharmaceutical Citalopram Product and Solutions

Table 49. Prinston Pharmaceutical Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. STI Pharma Corporate Information, Head Office, and Major Competitors

Table 51. STI Pharma Major Business

Table 52. STI Pharma Citalopram Product and Solutions

Table 53. STI Pharma Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. TEVA Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 55. TEVA Pharmaceutical Major Business

Table 56. TEVA Pharmaceutical Citalopram Product and Solutions

Table 57. TEVA Pharmaceutical Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Hexal Corporate Information, Head Office, and Major Competitors

Table 59. Hexal Major Business

Table 60. Hexal Citalopram Product and Solutions

Table 61. Hexal Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Shanghai Great Wall Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 63. Shanghai Great Wall Pharmaceutical Major Business

Table 64. Shanghai Great Wall Pharmaceutical Citalopram Product and Solutions

Table 65. Shanghai Great Wall Pharmaceutical Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Wanquan Wante Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 67. Wanquan Wante Pharmaceutical Major Business

Table 68. Wanquan Wante Pharmaceutical Citalopram Product and Solutions

Table 69. Wanquan Wante Pharmaceutical Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Northeast Pharmaceutical Group Corporate Information, Head Office, and Major Competitors

Table 71. Northeast Pharmaceutical Group Major Business

Table 72. Northeast Pharmaceutical Group Citalopram Product and Solutions

Table 73. Northeast Pharmaceutical Group Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Sichuan Kelun Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 75. Sichuan Kelun Pharmaceutical Major Business

Table 76. Sichuan Kelun Pharmaceutical Citalopram Product and Solutions

Table 77. Sichuan Kelun Pharmaceutical Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Kunming Jida Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 79. Kunming Jida Pharmaceutical Major Business

Table 80. Kunming Jida Pharmaceutical Citalopram Product and Solutions

Table 81. Kunming Jida Pharmaceutical Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Jiangsu Enhua Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 83. Jiangsu Enhua Pharmaceutical Major Business

Table 84. Jiangsu Enhua Pharmaceutical Citalopram Product and Solutions

Table 85. Jiangsu Enhua Pharmaceutical Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Southwest Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 87. Southwest Pharmaceutical Major Business

Table 88. Southwest Pharmaceutical Citalopram Product and Solutions

Table 89. Southwest Pharmaceutical Citalopram Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Global Citalopram Revenue (USD Million) by Players (2019-2021)

Table 91. Global Citalopram Revenue Share by Players (2019-2021)

Table 92. Breakdown of Citalopram by Company Type (Tier 1, Tier 2 and Tier 3)

Table 93. Citalopram Players Head Office, Products and Services Provided

Table 94. Citalopram Mergers & Acquisitions in the Past Five Years

Table 95. Citalopram New Entrants and Expansion Plans

Table 96. Global Citalopram Revenue (USD Million) by Type (2016-2021)

Table 97. Global Citalopram Revenue Share by Type (2016-2021)

Table 98. Global Citalopram Revenue Forecast by Type (2021-2026)

Table 99. Global Citalopram Revenue by Application (2016-2021)

Table 100. Global Citalopram Revenue Forecast by Application (2021-2026)

Table 101. North America Citalopram Revenue by Type (2016-2021) & (USD Million)

Table 102. North America Citalopram Revenue by Type (2021-2026) & (USD Million)

Table 103. North America Citalopram Revenue by Application (2016-2021) & (USD Million)

Table 104. North America Citalopram Revenue by Application (2021-2026) & (USD Million)

Table 105. North America Citalopram Revenue by Country (2016-2021) & (USD Million)

Table 106. North America Citalopram Revenue by Country (2021-2026) & (USD Million)

Table 107. Europe Citalopram Revenue by Type (2016-2021) & (USD Million)

Table 108. Europe Citalopram Revenue by Type (2021-2026) & (USD Million)

Table 109. Europe Citalopram Revenue by Application (2016-2021) & (USD Million)

Table 110. Europe Citalopram Revenue by Application (2021-2026) & (USD Million)

Table 111. Europe Citalopram Revenue by Country (2016-2021) & (USD Million)

Table 112. Europe Citalopram Revenue by Country (2021-2026) & (USD Million)

Table 113. Asia-Pacific Citalopram Revenue by Type (2016-2021) & (USD Million)

Table 114. Asia-Pacific Citalopram Revenue by Type (2021-2026) & (USD Million)

Table 115. Asia-Pacific Citalopram Revenue by Application (2016-2021) & (USD Million)

Table 116. Asia-Pacific Citalopram Revenue by Application (2021-2026) & (USD Million)

Table 117. Asia-Pacific Citalopram Revenue by Region (2016-2021) & (USD Million)

Table 118. Asia-Pacific Citalopram Revenue by Region (2021-2026) & (USD Million)

Table 119. South America Citalopram Revenue by Type (2016-2021) & (USD Million)

Table 120. South America Citalopram Revenue by Type (2021-2026) & (USD Million)

Table 121. South America Citalopram Revenue by Application (2016-2021) & (USD Million)

Table 122. South America Citalopram Revenue by Application (2021-2026) & (USD Million)

Table 123. South America Citalopram Revenue by Country (2016-2021) & (USD Million)

Table 124. South America Citalopram Revenue by Country (2021-2026) & (USD Million)

Table 125. Middle East & Africa Citalopram Revenue by Type (2016-2021) & (USD Million)

Table 126. Middle East & Africa Citalopram Revenue by Type (2021-2026) & (USD Million)

Table 127. Middle East & Africa Citalopram Revenue by Application (2016-2021) & (USD Million)

Table 128. Middle East & Africa Citalopram Revenue by Application (2021-2026) & (USD Million)

Table 129. Middle East & Africa Citalopram Revenue by Country (2016-2021) & (USD Million)

Table 130. Middle East & Africa Citalopram Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Citalopram Picture

Figure 2. Global Citalopram Revenue Market Share by Type in 2020

Figure 3. Solution

Figure 4. Tablets

Figure 5. Other

Figure 6. Citalopram Revenue Market Share by Application in 2020

Figure 7. Depression Picture

Figure 8. Generalized Anxiety Picture

Figure 9. Obsessive Compulsive Disorder Picture

Figure 10. Somatoform Disorder Picture

Figure 11. Schizophrenia Picture

Figure 12. Other Picture

Figure 13. Global Citalopram Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 14. Global Citalopram Revenue and Forecast (2016-2026) & (USD Million)

Figure 15. Global Citalopram Revenue Market Share by Region (2016-2026)

Figure 16. Global Citalopram Revenue Market Share by Region in 2020

Figure 17. North America Citalopram Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Europe Citalopram Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Asia-Pacific Citalopram Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. South America Citalopram Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Middle East and Africa Citalopram Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Citalopram Market Drivers

Figure 23. Citalopram Market Restraints

Figure 24. Citalopram Market Trends

Figure 25. H.Lundbeck A/S Recent Developments and Future Plans

Figure 26. Amneal Pharmaceuticals Recent Developments and Future Plans

Figure 27. Aurobindo Pharma Recent Developments and Future Plans

Figure 28. Hetero Drugs Recent Developments and Future Plans

Figure 29. Macleods Pharmaceuticals Recent Developments and Future Plans

Figure 30. Silarx Pharmacueticals Recent Developments and Future Plans

Figure 31. Apotex Recent Developments and Future Plans

Figure 32. Hikma Pharmaceuticals Recent Developments and Future Plans

Figure 33. Jubilant Pharma Recent Developments and Future Plans

Figure 34. Lupin Limited Recent Developments and Future Plans

Figure 35. Prinston Pharmaceutical Recent Developments and Future Plans

Figure 36. STI Pharma Recent Developments and Future Plans

Figure 37. TEVA Pharmaceutical Recent Developments and Future Plans

Figure 38. Hexal Recent Developments and Future Plans

Figure 39. Shanghai Great Wall Pharmaceutical Recent Developments and Future Plans

Figure 40. Wanquan Wante Pharmaceutical Recent Developments and Future Plans

Figure 41. Northeast Pharmaceutical Group Recent Developments and Future Plans

Figure 42. Sichuan Kelun Pharmaceutical Recent Developments and Future Plans

Figure 43. Kunming Jida Pharmaceutical Recent Developments and Future Plans

Figure 44. Jiangsu Enhua Pharmaceutical Recent Developments and Future Plans

Figure 45. Southwest Pharmaceutical Recent Developments and Future Plans

Figure 46. Global Citalopram Revenue Share by Players in 2020

Figure 47. Citalopram Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 48. Global Top 3 Players Citalopram Revenue Market Share in 2020

Figure 49. Global Top 10 Players Citalopram Revenue Market Share in 2020

Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 51. Global Citalopram Revenue Share by Type in 2020

Figure 52. Global Citalopram Market Share Forecast by Type (2021-2026)

Figure 53. Global Citalopram Revenue Share by Application in 2020

Figure 54. Global Citalopram Market Share Forecast by Application (2021-2026)

Figure 55. North America Citalopram Sales Market Share by Type (2016-2026)

Figure 56. North America Citalopram Sales Market Share by Application (2016-2026)

Figure 57. North America Citalopram Revenue Market Share by Country (2016-2026)

Figure 58. United States Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Canada Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Mexico Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Europe Citalopram Sales Market Share by Type (2016-2026)

Figure 62. Europe Citalopram Sales Market Share by Application (2016-2026)

Figure 63. Europe Citalopram Revenue Market Share by Country (2016-2026)

Figure 64. Germany Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. France Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. United Kingdom Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Russia Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Italy Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Asia-Pacific Citalopram Sales Market Share by Type (2016-2026)

Figure 70. Asia-Pacific Citalopram Sales Market Share by Application (2016-2026)

Figure 71. Asia-Pacific Citalopram Revenue Market Share by Region (2016-2026)

Figure 72. China Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Japan Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South Korea Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. India Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Southeast Asia Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Australia Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. South America Citalopram Sales Market Share by Type (2016-2026)

Figure 79. South America Citalopram Sales Market Share by Application (2016-2026)

Figure 80. South America Citalopram Revenue Market Share by Country (2016-2026)

Figure 81. Brazil Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Argentina Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Middle East and Africa Citalopram Sales Market Share by Type (2016-2026)

Figure 84. Middle East and Africa Citalopram Sales Market Share by Application (2016-2026)

Figure 85. Middle East and Africa Citalopram Revenue Market Share by Country (2016-2026)

Figure 86. Turkey Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. Saudi Arabia Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. UAE Citalopram Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 89. Methodology

Figure 90. Research Process and Data Source